C.R. Bard (NYSE: BCR) manufactures medical devices such as stents and catheters. The company leads in market share in nearly all its markets.
Oncology was one of Bard's fastest growing therapeutic areas, with over 19% sales growth. Cancer is the second leading cause of death in developed countries and the third worldwide, and people spend billions of dollars annually on cancer research and treatment.(Read more at Wikinvest )